Literature DB >> 28286018

Acyl glucuronide metabolites: Implications for drug safety assessment.

Terry R Van Vleet1, Hong Liu2, Anthony Lee2, Eric A G Blomme3.   

Abstract

Acyl glucuronides are important metabolites of compounds with carboxylic acid moieties and have unique properties that distinguish them from other phase 2 metabolites. In particular, in addition to being often unstable, acyl glucuronide metabolites can be chemically reactive leading to covalent binding with macromolecules and toxicity. While there is circumstantial evidence that drugs forming acyl glucuronide metabolites can be associated with rare, but severe idiosyncratic toxic reactions, many widely prescribed drugs with good safety records are also metabolized through acyl glucuronidation. Therefore, there is a need to understand the various factors that can affect the safety of acyl glucuronide-producing drugs including the rate of acyl glucuronide formation, the relative reactivity of the acyl glucuronide metabolite formed, the rate of elimination, potential proteins being targeted, and the rate of aglucuronidation. In this review, these factors are discussed and various approaches to de-risk the safety liabilities of acyl glucuronide metabolites are evaluated.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acyl glucuronides; Clinical; Elimination; Idiosyncratic; Metabolite; Pharmacokinetics; Preclinical; Protein binding; Reactive; Safety testing; Toxicology

Mesh:

Substances:

Year:  2017        PMID: 28286018     DOI: 10.1016/j.toxlet.2017.03.003

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  5 in total

1.  CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs.

Authors:  Mary Alexandra Schleiff; Samantha Crosby; Madison Blue; Benjamin Mark Schleiff; Gunnar Boysen; Grover Paul Miller
Journal:  Biochem Pharmacol       Date:  2021-11-05       Impact factor: 5.858

Review 2.  PXR-mediated idiosyncratic drug-induced liver injury: mechanistic insights and targeting approaches.

Authors:  Jingheng Wang; Monicah Bwayi; Rebecca R Florke Gee; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-06-16       Impact factor: 4.481

3.  Effects of p-Cresol on Oxidative Stress, Glutathione Depletion, and Necrosis in HepaRG Cells: Comparisons to Other Uremic Toxins and the Role of p-Cresol Glucuronide Formation.

Authors:  Sang Zhu; Yan Rong; Tony K L Kiang
Journal:  Pharmaceutics       Date:  2021-06-09       Impact factor: 6.321

4.  An adverse outcome pathway for immune-mediated and allergic hepatitis: a case study with the NSAID diclofenac.

Authors:  Saravanakumar Selvaraj; Jung-Hwa Oh; Jürgen Borlak
Journal:  Arch Toxicol       Date:  2020-05-05       Impact factor: 5.153

Review 5.  Chloro-s-triazines-toxicokinetic, Toxicodynamic, Human Exposure, and Regulatory Considerations.

Authors:  Khaled Abass; Olavi Pelkonen; Arja Rautio
Journal:  Curr Drug Metab       Date:  2021       Impact factor: 3.731

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.